Unknown

Dataset Information

0

ALK-positive histiocytosis with KIF5B-ALK fusion in the central nervous system.

ABSTRACT:

SUBMITTER: Lucas CG 

PROVIDER: S-EPMC6712982 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

ALK-positive histiocytosis with KIF5B-ALK fusion in the central nervous system.

Lucas Calixto-Hope G CG   Gilani Ahmed A   Solomon David A DA   Liang Xiayuan X   Maher Ossama M OM   Chamyan Gabriel G   Kleinschmidt-Demasters Bette K BK   Perry Arie A  

Acta neuropathologica 20190522 2

Similar Datasets

Unknown Novel actionable ROS1::GIT2 fusion in non-Langerhans cell histiocytosis with central nervous system involvement.
| S-EPMC9807475 | biostudies-literature
Unknown Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors.
| S-EPMC9159442 | biostudies-literature
Unknown Central Nervous System Disease in Patients With RET Fusion-Positive NSCLC Treated With Selpercatinib.
| S-EPMC10122712 | biostudies-literature
Unknown Central Nervous System Progression in Patients Receiving ALK-Targeted Central Nervous System–Penetrable Tyrosine Kinase Inhibitors: Treatment Patterns and Outcomes
| S-EPMC12621429 | biostudies-literature
Unknown Comparative Efficacy of ALK Inhibitors for Treatment-Naive ALK-Positive Advanced Non-Small Cell Lung Cancer with Central Nervous System Metastasis: A Network Meta-Analysis.
| S-EPMC9917367 | biostudies-literature
Unknown Profound and sustained response with next-generation ALK inhibitors in patients with relapsed or progressive ALK-positive anaplastic large cell lymphoma with central nervous system involvement.
| S-EPMC9425319 | biostudies-literature
Unknown ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition.
| S-EPMC8759533 | biostudies-literature
Unknown Multisystem ALK-positive histiocytosis: a multi-case study and literature review.
| S-EPMC10010018 | biostudies-literature
Transcriptomics RNA-seq of human NSCL cell lines with induced fusion genes; ALK-EML4-V1, ALK-EML4-V3, ALK-TFG, ALK-KIF5B
2022-12-18 | E-MTAB-11304 | biostudies-arrayexpress
Unknown Analysis of Baseline Molecular Factors Associated With the Risk of Central Nervous System Progression Among Alectinib-Treated Patients With ALK-Positive NSCLC.
| S-EPMC11532761 | biostudies-literature